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Abstract
Background: The importance of cell-cell junction proteins (including armadillo proteins) in tumor biology is
known, but limited with regard to plakophilins. We explored the relationship between plakophilins (PKP1, PKP2,
PKP3) to gastric cancer via immunohistochemical techniques.
Methods: We compared the immunohistochemistry of PKPs in 34 gastric adenocarcinomas and 20 normal gastric
tissues.
Results: In gastric cancer, PKP1 expression was unchanged but PKP2 and PKP3 were significantly decreased as
compared to normal controls. There was no observable clinical association with PKP1 or PKP2 expression; however,
low PKP3 level and poor prognosis appeared to correlate with regards to node number and tumor stage. The
mean disease-free survival (DFS) was 38 ± 3 months (range: 32 - 44) and mean overall survival (OS) 42 ± 4 months
(range: 38 - 50). Decreased PKP2 appeared to negatively impact DFS.
Conclusion: Decreased PKP2 and PKP3 may be early prognostic markers and loss of PKP3 expression during gastric
carcinoma progression may indicate an invasive phenotype.
Introduction
In the twentieth century, the highest number of cancer
related deaths worldwide was attributed to gastric can-
cer, a disease with a dismal course and outcome [1].
Alterations of intercellular adhesion are associated with
tumor dedifferentiation and invasion [2]. Armadillo-
related proteins regulate functions like cell-cell interac-
tion and cytoskeleton maintenance by producing and
transducing signals influencing gene expression [3].
p120 protein is an important constituent of intercellular
connections and a substrate of Src tyrosine kinase pro-
teins. The plakophilins (PKP1, PKP2, and PKP3) are
members of the armadillo-like protein subfamily, which
are related to p120 protein [4]. Cell differentiation is sig-
nificantly associated with the appearance of PKPs in
desmosomes [5,6]. However, in all desmosome-produ-
cing cell types, only PKP2 has been found [7]. PKPs are
fundamental for desmosome configuration and function
[8,9]. However, little is known about the biological sig-
nificance of armadillo proteins in tumorigenesis and
tumor progression. In head and neck squamous cell
carcinoma, PKP1 mRNA is significantly overexpressed
[9]. One study reported PKP2 as expressed in all adeno-
carcinomas [10]. In our study, we examined PKP1,
PKP2, and PKP3 expression and their clinicopathological
correlation with gastric cancer.
Materials and methods
Thirty-four gastric adenocarcinoma samples and 20 nor-
mal gastric tissue controls (patients with chronic gastri-
tis on endoscopy) were included. Study design was
approved by our institutional ethics committee and
informed written consent was obtained from all patients.
Hematoxylin-eosin sections were re-examined and
reclassified according to World Health Organization
(WHO) 2000 guidelines and the TNM staging system.
Tumors were grouped into two histologic types: diffuse
and intestinal. Additionally, depth of invasion (T),
lymph node metastasis (N), and level of lymphatic, vas-
cular, and perineural invasion were noted. Blocks of
tumors without areas of necrosis were immunohisto-
chemically studied for PKP1, PKP2, and PKP3. PKP
immunohistochemistry was compared with stage, patho-
logic characteristics, and survival.
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All tissues were routinely fixed using 10% neutral formalin
for 24 hours and subsequently embedded in paraffin. 4
μm-thick tissue sections from blocks were stained for
PKP1 (mouse monoclonal, IgG1, clone PP1; Progen, Hei-
delberg, Germany), PKP2 (mouse monoclonal multi-epi-
tope cocktail, IgG1, clone PP2762, PP2/86, PP2/150;
Progen, Heidelberg, Germany), and PKP3 (mouse mono-
c l o n a l ,I g G 2 b ,c l o n e2 3 E / 4 ;Z ymed, San Francisco, CA,
USA) using the streptavidin-biotin immunohistochemical
technique. PKP1 and PKP2 antibodies were ready for
immediate use. PKP3 was diluted to 1/100 after several
dilutions were tested. Sections were deparaffinized and
endogenous peroxidase activity was blocked using 3%
hydrogen peroxide for 10 minutes. For antigen retrieval,
sections were microwaved in 10 mM sodium citrate buffer
(pH 6.0) for 15 minutes at 98°C and cooled to room tem-
perature for 20 minutes, then rinsed in distilled water and
phosphate buffered saline (PBS). A Histostain -Plus Kit
(Zymed 2
nd generation, LAB-SA Detection System, Cat.
No. 85-9643, DAB kromogen, Zymed Laboratories, San
Francisco, CA, USA) was used next. After blocking solu-
tion (Reagent A) was applied for 10 minutes, PKP2 and
PKP3 antibodies were applied for 1 hour at 37°C. PKP1
was applied overnight at 4°C. Sections were incubated with
biotinylated anti-immunoglobulin (Reagent B) and peroxi-
dase conjugated streptavidin (Reagent C) for 10 minutes.
DAB application was performed with Reagents D1, D2,
and D3 for 7 minutes according to the manufacturers’
instructions. Sections were washed with phosphate buf-
fered saline (pH 7.6) until DAB application, then washed
with distilled water after DAB application. For counter-
staining, Mayer’s hematoxylin solution was used. As a
positive control for PKP1, PKP2, and PKP3, we used skin
stratified squamous epithelia. No staining was observed
when PBS was used instead of the primary antibody, con-
firming the specifity of the primary antibody. Results were
evaluated with a Leica HMLB45 (Germany, 2000) light
microscope. The immunostaining results were evaluated
by assigning a score based on the extent and intensity of
immunoreactivity. PKP-positive cells were reported as a
percentage of the total number of carcinoma cells. Based
on the extent of cell labeling, the immunostaining reaction
was classified as homogeneous (50% to 100%), focal (50%
to 10%), or negative (0% to 10%). Homogeneous staining
was scored as 6 (strong-brown), 5 (moderate-yellow), or 4
(weak-light yellow), and focal staining was scored as 3
(strong-brown), 2 (moderate-yellow), or 1 (weak-light yel-
low). A score of 0 indicated no staining [4].
Statistical analysis
The non-parametric Mann-Whitney test was used to
compare PKP expression between groups as the p-value
did not show a normal distribution according to the
Shapiro-Wilk test. Clinicopathologic characteristics and
relationships were evaluated by the Chi-squared and
Spearman’s tests. A p-value of ≤ 0.05 was considered to
be statistically significant. Survival curves were con-
structed using the Kaplan-Meier test.
Results
The mean age was 60.3 ± 9.7 (range 42-74) with a
female to male ratio of 8/26. The mean age of controls
Table 1 Demographic characteristics of gastric
adenocarcinoma study patients
Characteristics n (%)
Age (mean ± SD, range) (years) 60.3 ± 9.7, 42-74
Gender
Female 8 (24)
Male 26 (76)
Operation
Total Gastrectomy 13 (47)
Subtotal Gastrectomy 21 (53)
Localization
Cardia 10 (29)
Fundus/body 6 (18)
Antrum 13 (38)
Major curvatura 5 (15)
Lauren classification
Intestinal 24 (71)
Diffuse 10 (29)
Depth of invasion
T1 1 (3)
T2 2 (6)
T3 28 (82)
T4 3 (9)
Lymph node metastasis
N0 2 (6)
N1 18 (53)
N2 8 (24)
N3 6 (18)
Venous invasion 12 (35)
Lymphatic invasion 26 (76)
Perineural invasion 24 (71)
Stage
I 1 (3)
II 1 (3)
III 24 (71)
IV 8 (23)
DFS (mean ± sd, months) 38 ± 3 (32-44)
OS (mean ± sd, months) 42 ± 4 (38-50)
Clinical status
NED 25 (74)
Death 8 (24)
With disease 1 (2)
DFS; disease-free survival; OS; Overall survival; NED, no evidence of disease
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ratio was 5/15. There was no statistically significant
difference in age and sex between groups. Tumor loca-
tions were as follows: cardia 29.4% (n = 10), fundus/
body 17.6% (n = 6), antrum 38.2% (n = 13), and
greater curvature 14.7% (n = 5). 13 patients (47.1%)
underwent total gastrectomy and 21 patients (52.9%)
subtotal gastrectomy. Pathologic characteristics were as
follows: T (depth of invasion): T1 2.9% (n = 1), T2
5.9% (n = 2), T3 82.4% (n = 28), T4 8.8% (n = 3);
nodal metastasis (N): N0: 5.9% (n = 2), N1 (1-6): 52.9%
(n = 18), N2 (7-15): 23.5% (n = 8), N3 (> 15): 17.6% (n
= 6). Stage classification was: Stage I: 2.9% (n = 1),
Stage II: 2.9% (n = 1), Stage III: 70.6% (n = 24), Stage
IV: 23.5% (n = 8). The following levels of invasions
were noted: vascular 35.3% (n = 12), lymphatic 76.5%
(n = 26), and perineural 70.6% (n = 24). 10 patients
(29.%) were of the diffuse type and 24 patients (71%)
were of the intestinal type (Table 1). All patients
underwent postoperative chemoradiation. We observed
cytoplasmic staining in 23 of 34 (68%) patients with
PKP1, in 26 of 34 (76%) patients with PKP2, and in 25
of 34 (74%) patients with PKP3 (Figure 1). A few
patients showed slight membranous staining in addi-
tion to cytoplasmic staining with PKP2 and PKP3
(Figure 1). In controls, strong cytoplasmic staining was
o b s e r v e dw i t hP K P 1i n1 5o f2 0( 7 5 % )p a t i e n t s ,w i t h
PKP2 in 20 of 20 (100%) patients, and with PKP3 in
18 of 20 (90%) patients (Figure 2). A few cells stained
partially membranous with PKP2 in controls. In some
controls, background staining was observed with PKP1.
There was no difference in PKP1 expression (p =
0.628) between groups, but PKP2 and PKP3 expression
was significantly decreased in gastric cancer compared
with controls (p = 0.0000001, 0.0001, respectively;
Table 2).
The staining state was separated into two parts for
clinical evaluation: 0-4 and 5-6. Stages I and II were
excluded from this portion of the study because they
contained only one patient each. Although there was no
significant correlation between PKP1 and PKP2 expres-
sion and clinical characteristics, we demonstrated a
negative correlation between decreased PKP3 expression
and node number and stage (p = 0.033, p = 0.007,
respectively; Tables 3, 4). Local recurrences occurred in
3 patients. Eight patients developed distant metastases
(bone, 3 patients; liver, 3 patients; and lung, 2 patients).
The mean disease-free survival (DFS) was 38 ± 3 (range:
32 - 44) months and mean overall survival (OS) was 42
± 4 (range: 38-50) months (long rank test). There was a
Figure 1 Plakophilin immunostaining in gastric adenocar-cinoma. Focal, moderate cytoplasmic staining with PKP1(A) and PKP3(B); partial
membranous staining in addition to focal, moderate cytoplasmic staining with PKP2(C) (×400).
Figure 2 Plakophilin immunostaining in normal gastric glands. Homogeneous and strong cytoplasmic staining of PKP1(A), PKP2(B) and PKP3
(C) (×400).
Demirag et al. Diagnostic Pathology 2011, 6:1
http://www.diagnosticpathology.org/content/6/1/1
Page 3 of 5significant association between decreased PKP2 expres-
sion and DFS (p = 0.02, Table 4).
Discussion
Plakophilins are structural proteins and a constitutive
part of the cytoplasmic plaques of desmosomes. They
are engaged in the linkage of other desmosomal proteins
and the recruitment of intermediate desmosomal pro-
teins, and thus confer stability and adhesion of cells and
tissues during normal development [11-13]. Recently,
the clinical importance of these proteins has been stu-
died [4,8-10,14].
PKP1 is the member of the armadillo multigene family
most closely related to p120, and is thought to play a
key role in stabilizing the interaction between desmo-
somes and the cytoskeleton in stratified squamous and
complex epithelia [15]. PKP1 immunoreactivity inversely
correlates with tumor grade in oropharyngeal squamous
cell carcinoma (SCC) and adenocarcinoma [4,7]. In our
study, however, we did not demonstrate a difference in
PKP1 expression as compared to controls, or any clini-
cal correlation for that matter.
PKP2 is present in desmosomal plaques from simple
epithelium and nonepithelial tissues, and in the nucleus,
whether or not desmosomes are present. This suggests
that in cells lacking desmosomes, PKP2 may function
exclusively in the nucleus [5,10]. Papagerakis et al. [4]
showed a significant relationship between strong PKP2
immunoreactivity and metastasis in oropharyngeal SCC.
In our cohort, we not only showed significantly
decreased PKP2 immunoreactivity in gastric cancer tis-
sue, but also found a significant correlation between
decreased expression and a shortened DFS.
PKP3 is also present in desmosomes from simple and
stratified epithelia [10]. Papagerakis et al. [4] stated that
decreased PKP3 activity is inversely correlated with his-
tological grade in oropharyngeal SCC. Reduced immu-
noreactivity (0-4) for PKP3 was observed primarily in
poorly differentiated grade III tumors and correlated
with poor survival. In contrast, Furukawa et al. [14] sta-
ted that PKP3 staining intensity in lung adenocarcinoma
correlated with poor survival. PKP3 expression was sig-
nificantly associated with nodal status and tumor size.
Schwarz et al. [7] observed stronger PKP3 immunoreac-
tivity in pancreatic adenocarcinoma tissue compared
with normal pancreatic tissue. In our study on gastric
adenocarcinoma, loss of PKP3 expression inversely cor-
related with nodal status and stage. Decreased PKP2
and PKP3 expression may be an early step in tumor
transformation. Decreased PKP3 expression results in
decreased desmosome assembly, and increased cell
motility and invasion. These data lead us to propose
that loss of PKP3 expression during gastric carcinoma
progression may indicate an invasive phenotype. In light
of these data, we suggest that during gastric carcinoma
progression, the loss of PKP2 and PKP3 expression cor-
relates with an invasive phenotype.
Initially, PKPs were identified as desmosomal plaque
proteins. Subsequent studies revealed that PKPs are
cytoplasmic and nuclear proteins translocated to desmo-
somes only during certain stages of differentiation [5,6].
Papagerakis et al. [4] detected membranous and cyto-
plasmic staining for PKP1, PKP2, PKP3, and PKP4 in
oropharyngeal SCC. In their study, a cytoplasmic loca-
tion was associated with distant metastases in PKP2,
local failure in PKP1, and poor clinical outcome in
PKP3. Besides abundant desmosomal staining for both
PKP2 and PKP3 with apical polarity, Schwarz et al. [7]
observed cytoplasmic staining for PKP3 in some adeno-
carcinomas. They confirmed the existence of cytoplas-
mic PKP3 by Western blot analysis. We observed
cytoplasmic staining for PKP1, PKP2, and PKP3 in gas-
tric carcinoma. To explain the significance of PKP loca-
tion in various tumors, studies with larger numbers of
patients with different tumors are required.
In summary, present study has identified the signifi-
cantly decreased PKP2 and PKP3 immunoreactivity in
gastric adenocarcinoma. The loss of PKP3 expression
was found to be correlated with poor prognistic clinico-
pathological features that increased node number and
advance stage of tumor. In addition, decreased PKP2
Table 3 Correlation between PKP3 expression and nodal
metastasis
Immunohistochemistry Lymph node status (n = 32 cases)
N0 N1 N2 N3
0-4 7 6 6
5-6 1 10 2
Chi-squared test; p = 0.033
Table 4 Correlation between PKP3 expression and tumor
stage
Immunohistochemistry Staining (n = 32 cases) Stage III Stage IV
0-4 11 8
5-6 13 0
Chi-squared test; p = 0.007
Table 2 Immunohistochemistry of gastric cancer and
control groups
Plakophilin expression
(mean ± sd) (range)*
Gastric cancer
n=3 4
Controls
n=2 0
p-value**
PKP1 3.42 ± 2.55 (0-6) 3.60 ± 2.55 (0-6) 0.628
PKP2 2.06 ± 2.02 (0-6) 5.60 ± 0.50 (5-6) 0.0000001
PKP3 2.44 ± 2.50 (0-6) 5.00 ± 1.86 (0-6) 0.0001
*Plakophilin expression were graded according to 4 .
**Non-parametric (Mann Whitney U Test)
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of this study suggest that loss of PKP2 and PKP3 pro-
teins may have significant role in the prognosis of gas-
tric adenocarcinoma, however further invastigation
including larger case series is needed.
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